helpline 01494 601 400

Zogenix

Phase 3 clinical trial announced for Dravet Syndrome drug

The second Phase 3 clinical trial is to begin for ZX008, a branded version of low-dose fenfluramine, designed as an adjunctive treatment of seizures in children with Dravet syndrome.

Subscribe to RSS - Zogenix